Nutriband Inc. (NTRB)
NTRB moved a median of 0.00% 30 minutes after news, and +0.26% by the close. How NTRB actually reacts to news — the realized, point-in-time move the market made, measured across 143 labeled events over the last three years with zero look-ahead.
NTRB’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 43% | 113 |
| 30-min | 0.00% | 44% | 125 |
| 60-min | 0.00% | 45% | 134 |
| to close | +0.26% | 52% | 143 |
| Middle 50% of NTRB reactions | -1.73% to +2.40% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 143 |
Half of all Nutriband Inc. news events land between -1.73% and +2.40% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when NTRB moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to NTRB's baseline. Nothing else.
Recent NTRB events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274 | Press release | GlobeNewswire | +0.00% | +10.70% | |
| Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology | Press release | GlobeNewswire | +0.00% | -10.37% | |
| Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders | Press release | GlobeNewswire | +1.48% | -2.41% | |
| Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis | Press release | GlobeNewswire | +3.13% | -0.72% | |
| Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board | Press release | GlobeNewswire | -2.64% | -11.99% | |
| Form 8-K NutriBand Inc. For: Sep 21 | SEC filing · Form 8-K | SEC EDGAR | +1.29% | +22.31% | |
| Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing | Press release | GlobeNewswire | -2.65% | -10.58% | |
| Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit | Press release | GlobeNewswire | -0.81% | -5.69% | |
| Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch | Press release | GlobeNewswire | +0.33% | +0.33% | |
| Form 10-Q NutriBand Inc. For: Jul 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.33% | +0.33% | |
| Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight | Press release | GlobeNewswire | +0.00% | +1.92% | |
| Form 8-K NutriBand Inc. For: Jun 01 | SEC filing · Form 8-K | SEC EDGAR | +4.36% | +4.36% | |
| Form 10-Q NutriBand Inc. For: Apr 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.28% | -3.42% | |
| Form 10-K/A NutriBand Inc. For: Jan 31 | SEC filing · Form 10-K | SEC EDGAR | +0.70% | +0.29% | |
| Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference | Press release | GlobeNewswire | +0.00% | +2.56% | |
| Form 10-K NutriBand Inc. For: Jan 31 | SEC filing · Form 10-K | SEC EDGAR | +0.79% | +1.98% | |
| Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast | Press release | GlobeNewswire | — | -0.95% | |
| Form 8-K NutriBand Inc. For: Mar 30 | SEC filing · Form 8-K | SEC EDGAR | — | +4.96% | |
| Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica | Press release | GlobeNewswire | — | +0.26% | |
| Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica | Press release | GlobeNewswire | +1.26% | +7.96% | |
| Form 8-K NutriBand Inc. For: Feb 13 | SEC filing · Form 8-K | SEC EDGAR | +1.26% | +7.96% | |
| Form 8-K NutriBand Inc. For: Jan 24 | SEC filing · Form 8-K | SEC EDGAR | — | -0.44% | |
| Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points | Press release | GlobeNewswire | +1.29% | +3.23% | |
| Nutriband CEO Publishes Letter to Shareholders | Press release | GlobeNewswire | -2.38% | -1.73% | |
| Form 8-K NutriBand Inc. For: Dec 30 | SEC filing · Form 8-K | SEC EDGAR | -2.38% | -1.73% | |
| Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio | Press release | GlobeNewswire | +13.86% | +10.30% | |
| Form DEF 14A NutriBand Inc. For: Jan 24 | SEC filing · Form DEF | SEC EDGAR | — | -0.35% | |
| Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction | Press release | GlobeNewswire | +4.05% | +2.03% | |
| Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration | Press release | GlobeNewswire | +4.05% | +2.03% | |
| Form 10-Q NutriBand Inc. For: Oct 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.63% | +5.07% | |
| Form 8-K NutriBand Inc. For: Oct 28 | SEC filing · Form 8-K | SEC EDGAR | — | +2.78% | |
| Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch | Press release | GlobeNewswire | -1.18% | +1.44% | |
| REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch | Press release | GlobeNewswire | -6.07% | -0.77% | |
| Nutriband Co-Founder Gareth Sheridan Returns as CEO | Press release | GlobeNewswire | +0.00% | -0.71% | |
| Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch | Press release | GlobeNewswire | +0.00% | -4.21% | |
| Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology | Press release | GlobeNewswire | +2.75% | +6.25% | |
| Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference | Press release | GlobeNewswire | +2.75% | +6.25% | |
| Nutriband Inc. to Present at the MicroCap Rodeo Conference | Press release | GlobeNewswire | -1.87% | -0.83% | |
| Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl | Press release | GlobeNewswire | -1.12% | -1.64% | |
| Form 10-Q NutriBand Inc. For: Jul 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.12% | -1.64% | |
| Form 8-K NutriBand Inc. For: Feb 01 | SEC filing · Form 8-K | SEC EDGAR | — | -2.01% | |
| Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000 | Press release | GlobeNewswire | +0.00% | +0.16% | |
| Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025 | Press release | GlobeNewswire | -1.06% | -3.93% | |
| Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election | Press release | GlobeNewswire | -1.37% | -1.15% | |
| FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch | Press release | GlobeNewswire | -0.07% | -0.83% | |
| Form 8-K NutriBand Inc. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | -0.07% | -0.83% | |
| Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval | Press release | GlobeNewswire | +0.05% | +3.97% | |
| Form 8-K NutriBand Inc. For: Jul 14 | SEC filing · Form 8-K | SEC EDGAR | +0.50% | +0.99% | |
| Form EFFECT NutriBand Inc. | SEC filing · Form EFFECT | SEC EDGAR | -2.96% | -13.66% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the NTRB section they belong to.
Where else NTRB is measured.
NTRB earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Propanc Biopharma, Inc. (PPCB) | 144 | 0.00% | 41% |
| Cara Therapeutics, Inc. (CARA) | 143 | -0.56% | 46% |
| Redhill Biopharma Ltd. - American Depositary Shares (RDHL) | 143 | -0.50% | 39% |
| Alimera Sciences, Inc. (ALIM) | 142 | 0.00% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Nutriband Inc.'s median reaction calculated?
Every labeled NTRB news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 143 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 44% of NTRB's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does NTRB's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.